Regeneron Announces Positive Phase 2 Data Evaluating Fel d 1 Antibody Cocktail in Cat-allergic Patients with Mild Asthma

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. TSLA
3. WBD
4. USO
5. AMC
6. MSFT
7. AMZN
8. ACN
9. FFAI
10. PAA

Go back to Regeneron Announces Positive Phase 2 Data Evaluating Fel d 1 Antibody Cocktail in Cat-allergic Patients with Mild Asthma
Regeneron (NASDAQ: REGN) Delayed: 789.45 +4.60 (0.59%)
Previous Close $784.85    52 Week High $592.36 
Open $786.03    52 Week Low $325.35 
Day High $792.68    P/E 207.20 
Day Low $779.96    EPS $3.81 
Volume 85,476